Quantitative assessment of dietary supplement intake in 77,000 French adults: impact on nutritional intake inadequacy and excessive intake.
Dietary supplements
Drug interactions
Nutrient intake inadequacy
Tolerable upper intake levels
Journal
European journal of nutrition
ISSN: 1436-6215
Titre abrégé: Eur J Nutr
Pays: Germany
ID NLM: 100888704
Informations de publication
Date de publication:
Oct 2019
Oct 2019
Historique:
received:
13
04
2018
accepted:
06
09
2018
pubmed:
8
10
2018
medline:
19
3
2020
entrez:
8
10
2018
Statut:
ppublish
Résumé
Dietary supplements (DS) are largely consumed in Western countries without demonstrating their nutritional benefits and safety in the general population. The aims, in a large population-based study of French adults, were: (1) to compare the prevalence of nutrient intake inadequacy and the proportion of individuals exceeding tolerable upper intake levels (UL) between DS users and non-users, and (2) to quantify the extent of potentially "at-risk" DS use practices (e.g., DS/drugs contraindicated association or use of beta-carotene DS in smokers). 76,925 participants, 47.6% men and 52.4% women, mean age 46.9 ± 16.3 years were enrolled to the NutriNet-Santé cohort and they completed a quantitative DS questionnaire and three 24 h dietary records. A composition database including > 8000 DS was developed. Variance reduction was applied to estimate usual intakes and analyses were weighted according to the French census data. Among DS users of the specific nutrient, DS contributed to 41% of total intake for vitamin D in men, 55% in women; and to 20% of total intake for pyridoxine in men, 21% in women. Compared to dietary intakes only, their prevalence of inadequacy was reduced by 11% for vitamin C, 9% for magnesium, 6% for pyridoxine in men, and 19% for calcium, 12% for iron, and 11% for magnesium in women (p < 0.0001). The proportion of subjects exceeding UL reached 6% for iron and 5% for magnesium in men, and 9% for iron in women. 6% of DS users had potentially "at-risk" practices. While DS use contributed to decrease the prevalence of insufficient intake for several nutrients, it also conveyed excessive intake of iron and magnesium. Besides, a substantial proportion of potentially "at-risk" DS use practices was reported.
Sections du résumé
BACKGROUND
BACKGROUND
Dietary supplements (DS) are largely consumed in Western countries without demonstrating their nutritional benefits and safety in the general population. The aims, in a large population-based study of French adults, were: (1) to compare the prevalence of nutrient intake inadequacy and the proportion of individuals exceeding tolerable upper intake levels (UL) between DS users and non-users, and (2) to quantify the extent of potentially "at-risk" DS use practices (e.g., DS/drugs contraindicated association or use of beta-carotene DS in smokers).
METHODS
METHODS
76,925 participants, 47.6% men and 52.4% women, mean age 46.9 ± 16.3 years were enrolled to the NutriNet-Santé cohort and they completed a quantitative DS questionnaire and three 24 h dietary records. A composition database including > 8000 DS was developed. Variance reduction was applied to estimate usual intakes and analyses were weighted according to the French census data.
RESULTS
RESULTS
Among DS users of the specific nutrient, DS contributed to 41% of total intake for vitamin D in men, 55% in women; and to 20% of total intake for pyridoxine in men, 21% in women. Compared to dietary intakes only, their prevalence of inadequacy was reduced by 11% for vitamin C, 9% for magnesium, 6% for pyridoxine in men, and 19% for calcium, 12% for iron, and 11% for magnesium in women (p < 0.0001). The proportion of subjects exceeding UL reached 6% for iron and 5% for magnesium in men, and 9% for iron in women. 6% of DS users had potentially "at-risk" practices.
CONCLUSION
CONCLUSIONS
While DS use contributed to decrease the prevalence of insufficient intake for several nutrients, it also conveyed excessive intake of iron and magnesium. Besides, a substantial proportion of potentially "at-risk" DS use practices was reported.
Identifiants
pubmed: 30293178
doi: 10.1007/s00394-018-1815-x
pii: 10.1007/s00394-018-1815-x
doi:
Types de publication
Evaluation Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2679-2692Références
Br J Clin Pharmacol. 2015 Apr;79(4):578-92
pubmed: 25251944
BMC Public Health. 2010 May 11;10:242
pubmed: 20459807
Eur J Epidemiol. 2010 May;25(5):287-96
pubmed: 20191377
Pharmacotherapy. 2011 May;31(5):490-502
pubmed: 21923430
Complement Ther Med. 2004 Jun-Sep;12(2-3):90-8
pubmed: 15561518
Eur J Nutr. 2019 Jun;58(4):1579-1590
pubmed: 29721678
Int J Obes Relat Metab Disord. 2000 Sep;24(9):1119-30
pubmed: 11033980
Am J Epidemiol. 2012 Feb 15;175(4):340-7
pubmed: 22273536
J Med Internet Res. 2013 Aug 08;15(8):e152
pubmed: 23928492
J Am Diet Assoc. 2006 Oct;106(10):1556-63
pubmed: 17000188
Eur J Clin Nutr. 1991 Dec;45(12):569-81
pubmed: 1810719
J Acad Nutr Diet. 2014 Nov;114(11):1784-90.e2
pubmed: 24703929
Thromb Res. 2005;117(1-2):7-13; discussion 39-42
pubmed: 16076481
Thromb Res. 2005;117(1-2):81-6; discussion 113-5
pubmed: 15921725
Am J Cardiol. 1996 Mar 1;77(7):545-6
pubmed: 8629604
J Am Diet Assoc. 2006 Oct;106(10):1575-87
pubmed: 17000190
Int J Clin Pract. 2012 Nov;66(11):1056-78
pubmed: 23067030
JAMA Intern Med. 2016 Apr;176(4):473-82
pubmed: 26998708
J Acad Nutr Diet. 2016 Mar;116(3):427-438.e5
pubmed: 26522988
Br J Nutr. 2015 Apr 28;113(8):1319-29
pubmed: 25826598
J Am Diet Assoc. 2007 Aug;107(8):1322-32
pubmed: 17659898
Natl Health Stat Report. 2015 Feb 10;(79):1-16
pubmed: 25671660
J Epidemiol Community Health. 2015 Sep;69(9):893-8
pubmed: 25832451
Adv Clin Exp Med. 2014 Jul-Aug;23(4):657-63
pubmed: 25166453
Am J Clin Nutr. 2007 Jan;85(1):280S-284S
pubmed: 17209210
Disabil Health J. 2015 Apr;8(2):240-9
pubmed: 25306424
Am J Clin Nutr. 1998 Aug;68(2):311-8
pubmed: 9701188
Cardiovasc Ther. 2010 Aug;28(4):246-53
pubmed: 20633025
J Am Diet Assoc. 2001 Mar;101(3):294-301
pubmed: 11269606
Eur J Clin Nutr. 2009 Nov;63 Suppl 4:S226-38
pubmed: 19888276
Int J Cancer. 2010 Jul 1;127(1):172-84
pubmed: 19876916
Food Nutr Res. 2009 Nov 12;53:
pubmed: 20011225
Br J Nutr. 2011 Apr;105(7):1055-64
pubmed: 21080983
Am J Clin Nutr. 2007 Jan;85(1):269S-276S
pubmed: 17209208
Eur J Clin Nutr. 2009 Jan;63(1):39-47
pubmed: 17882135
Public Health Nutr. 1999 Mar;2(1):23-33
pubmed: 10452728
PLoS One. 2013 May 09;8(5):e64255
pubmed: 23671711
J Acad Nutr Diet. 2012 May;112(5):657-663.e4
pubmed: 22709770
Eur J Clin Nutr. 2009 Feb;63(2):273-81
pubmed: 17940542
Food Nutr Res. 2011;55:
pubmed: 21909288
J Natl Cancer Inst. 2005 Sep 21;97(18):1338-44
pubmed: 16174855
Regul Toxicol Pharmacol. 2015 Dec;73(3):859-65
pubmed: 26482404
Eur J Clin Nutr. 2000 May;54(5):395-404
pubmed: 10822286
Int J Public Health. 2011 Aug;56(4):407-17
pubmed: 21538094
Br J Nutr. 2015 Mar 28;113(6):953-62
pubmed: 25772032
Br J Nutr. 2013 Oct;110(8):1480-91
pubmed: 23432948